Report on Business Magazine Top 1000 - Company Snapshot

VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The company is focused on the development and commercialization of medicines that address unmet medical needs in specialty CNS markets.

Address: 2150 St. Elzear Blvd. West , Laval, QC, H7L 4A8
Phone: 514 - 744-6792
Fax: 514 - 744-6272
Web Site:www.valeant.com
E-Mail:ir@valeant.com
CEO: J. Michael Pearson, Chairman & C.E.O.
CFO: Howard B. Schiller, E.V.P. & C.F.O.
HR : Brian Stolz, E.V.P. of Administration & CHC

LATEST ANNUAL FINANCIALS
Date of Balance Sheet: 31-Dec-2014
12 Months, US$
Total Revenue ($000): 8,561,100
% Change Revenue: 48.0
Profit/Loss ($000): 913,500
Employees: 16,800

GENERAL INFORMATION
Stock Symbol: VRX
Exchanges: TORONTO NEW YORK
Industry: BIOTECHNOLOGY & PHARMACEUTICAL
Company Type: PUBLIC
Company Status: ACTIVE


For more information on this company or any other North America publicly traded stock try globeinvestor.com.

© Copyright 2007 CTVglobemedia Publishing Inc. All Rights Reserved.
Last Updated 24-Oct-2015